Literature DB >> 12370350

A minimal IFN-gamma promoter confers Th1 selective expression.

Mohammed Soutto1, Feng Zhang, Ben Enerson, Yingkai Tong, Mark Boothby, Thomas M Aune.   

Abstract

Th1 and Th2 cells differentiate from naive precursors to effector cells that produce either IFN-gamma or IL-4, respectively. To identify transcriptional paths leading to activation and silencing of the IFN-gamma gene, we analyzed transgenic mice that express a reporter gene under the control of the 5' IFN-gamma promoter. We found that as the length of the promoter is increased, -110 to -225 to -565 bp, the activity of the promoter undergoes a transition from Th1 nonselective to Th1 selective. This is due, at least in part, to a T box expressed in T cells-responsive unit within the -565 to -410 region of the IFN-gamma promoter. The -225 promoter is silent when compared with the -110 promoter and silencing correlates with Yin Yang 1 binding to the promoter. The p38 mitogen-activated protein kinase signaling pathway, which also regulates IFN-gamma gene transcription, regulates the -70- to -44-bp promoter element. Together, the results demonstrate that a minimal IFN-gamma promoter contains a T box expressed in T cells responsive unit and is sufficient to confer Th1 selective expression upon a reporter.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12370350     DOI: 10.4049/jimmunol.169.8.4205

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Long-range histone acetylation of the Ifng gene is an essential feature of T cell differentiation.

Authors:  Weisong Zhou; Shaojing Chang; Thomas M Aune
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

2.  Histone hyperacetylated domains across the Ifng gene region in natural killer cells and T cells.

Authors:  Shaojing Chang; Thomas M Aune
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-14       Impact factor: 11.205

3.  T-bet antagonizes mSin3a recruitment and transactivates a fully methylated IFN-gamma promoter via a conserved T-box half-site.

Authors:  Yingkai Tong; Thomas Aune; Mark Boothby
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-31       Impact factor: 11.205

4.  T-bet-dependent expression of osteopontin contributes to T cell polarization.

Authors:  Mari L Shinohara; Marianne Jansson; Eun Sook Hwang; Miriam B F Werneck; Laurie H Glimcher; Harvey Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-14       Impact factor: 11.205

5.  Genetic variation at a Yin-Yang 1 response site regulates the transcription of cyclin-dependent kinase inhibitor p18INK4C transcript in lupus-prone mice.

Authors:  Hari-Hara S K Potula; Laurence Morel
Journal:  J Immunol       Date:  2012-04-13       Impact factor: 5.422

Review 6.  Epigenetics and T helper 1 differentiation.

Authors:  Thomas M Aune; Patrick L Collins; Shaojing Chang
Journal:  Immunology       Date:  2008-12-18       Impact factor: 7.397

7.  MAPKAP kinase 3 suppresses Ifng gene expression and attenuates NK cell cytotoxicity and Th1 CD4 T-cell development upon influenza A virus infection.

Authors:  Katharina Köther; Carolin Nordhoff; Dörthe Masemann; Georg Varga; Jay H Bream; Matthias Gaestel; Viktor Wixler; Stephan Ludwig
Journal:  FASEB J       Date:  2014-06-16       Impact factor: 5.191

8.  T-bet dependent removal of Sin3A-histone deacetylase complexes at the Ifng locus drives Th1 differentiation.

Authors:  Shaojing Chang; Patrick L Collins; Thomas M Aune
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

Review 9.  Epigenetic control of cytokine gene expression: regulation of the TNF/LT locus and T helper cell differentiation.

Authors:  James V Falvo; Luke D Jasenosky; Laurens Kruidenier; Anne E Goldfeld
Journal:  Adv Immunol       Date:  2013       Impact factor: 3.543

10.  Yin-Yang 1 regulates effector cytokine gene expression and T(H)2 immune responses.

Authors:  Jia Guo; Xin Lin; Marc A Williams; Qutayba Hamid; Steve N Georas
Journal:  J Allergy Clin Immunol       Date:  2008-04-18       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.